Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest Clostridium Stories

2013-04-08 08:27:31

EXTON, Pa., April 8, 2013 /PRNewswire/ -- BioTrends Research Group and Arlington Medical Resources in their TreatmentTrends(®): Clostridium difficile Infections (EU) report find that the lack of hospital formulary inclusion, perceived high cost and reimbursement challenges, and lack of familiarity are the top three barriers to prescribing of Optimer/Cubist/Astellas' Dificlir (fidaxomicin) among surveyed physicians in the EU5. Fewer than 40 percent of represented hospitals in the EU5...

2013-03-28 11:55:55

A strain of probiotic bacteria that can fight harmful bacterial infections in poultry has the ability to change its coat, according to new findings from the Institute of Food Research. The probiotic is currently being taken forward through farm-scale trials to evaluate how well it combats Clostridium perfringens — a cause of necrotic enteritis in poultry and the second most common cause of food poisoning in the UK The researchers at IFR, which is strategically funded by the...

2013-02-21 23:04:11

Diet Doc´s has advanced their prescription hCG diets to be a more cost-effective and safe alternative to gastric injections of botulinum toxin A (BTA) that are proven to be largely ineffective in fast weight loss. San Francisco, CA (PRWEB) February 21, 2013 Diet Doc´s prescription hCG diets have now been customized to produce fast weight loss at a fraction of the cost of gastric Botox injections, which offer no benefit in terms of body weight loss. Though Botox is one of the most...

2013-02-20 23:04:48

In a paper published today in the journal PLOS ONE, scientists from Biolog, Inc. reported on the use of Phenotype MicroArray technology as a general method that enables the determination of environmental signals that can activate or repress production of toxins by pathogenic microorganisms. Hayward, CA (PRWEB) February 20, 2013 Regulation of Microbial Toxin Production: A Novel Application of Biolog´s Phenotype MicroArray Technology In a paper published today in the journal PLOS ONE,...

2013-02-14 08:29:00

JERSEY CITY, N.J., Feb. 14, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the February 2013 Journal of the American Geriatrics Society published results from a multivariate analysis demonstrating that advancing age is a predictor of deterioration in treatment outcomes in patients with Clostridium difficile infection (CDI). The analysis was performed using data from two large, randomized Phase 3 clinical studies that compared the efficacy of...

2013-01-23 10:17:53

Children with eczema have a more diverse set of bacteria in their guts than non affected children, finds a new study in BioMed Central's open access journal BMC Microbiology. The types of bacteria present were also more typical of adult gut microbes than for toddlers without eczema. Eczema is a chronic inflammation of the epidermis. The gut bacteria of children with or without eczema was examined when they were six and 18 months old. At six months all the infants had the same types of...

2013-01-21 12:23:26

OTTAWA, Jan. 21, 2013 /CNW/ - In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products revise their product labels to reflect that each product has its own individual potency and as such, is not interchangeable with other botulinum products. The labelling changes are due to a risk evaluation of the active ingredients (Clostridium botulinum...

2012-12-17 08:25:53

GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) for Progenics' Clostridium difficile late-stage preclinical program. The agreement was led by MedImmune's Infectious Diseases & Vaccines Innovative Medicines (iMed) Unit. Clostridium difficile infections are the leading cause of hospital-acquired bacterial infections in the U.S. and...

2012-12-10 17:03:48

Researchers track the emergence and global spread of healthcare associated Clostridium difficile Researchers show that the global epidemic of Clostridium difficile 027/NAP1/BI in the early to mid-2000s was caused by the spread of two different but highly related strains of the bacterium rather than one as was previously thought. The spread and persistence of both epidemics were driven by the acquisition of resistance to a frontline antibiotic. Unlike many other healthcare-associated...

2012-12-04 16:26:11

OTTAWA, Dec. 4, 2012 /CNW/ - Health Canada is advising parents and caregivers not to feed honey to infants less than one year of age. Honey is the only food in Canada to which infant botulism has been linked. Healthy children over one year of age can safely eat honey because they have a very low risk of developing infant botulism. Infant botulism is caused by bacteria called Clostridium botulinum, which commonly exist in nature. Although the bacteria are unable to grow...


Latest Clostridium Reference Libraries

0_d6572564d3305dc462f4641398789e11
2011-04-15 13:32:47

Clostridium botulinum is a gram-positive, rod-shaped bacterium that produces neurotoxins, known as botulinum neurotoxins types A-G, that cause the flaccid muscular paralysis seen in botulism. It is the main paralytic agent in botox and is commonly found in soil. It is also an obligate anaerobe, meaning oxygen is poisonous to the cells. Superoxide dismutase helps C. botulinum tolerate traces of oxygen. It was first recognized and isolated in 1895 by Emile van Ermengem. Subsequent outbreaks...

More Articles (1 articles) »